R&D Trends Driving Broad Change In Surging Oncology Sector
$250bn Market Forecast By 2024
Executive Summary
Accounting for nearly a third of the global clinical pipeline, the oncology sector is set to grow to $250bn in sales by 2024 predicts a new report, identifying five research trends driving broad changes. COVID-19 has impacted trials, with 2% having been slowed down, suspended or discontinued.